Maider Zabala

4.5k total citations · 2 hit papers
22 papers, 2.5k citations indexed

About

Maider Zabala is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Maider Zabala has authored 22 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Genetics. Recurrent topics in Maider Zabala's work include Cancer Cells and Metastasis (8 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Maider Zabala is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Maider Zabala collaborates with scholars based in United States, Spain and Netherlands. Maider Zabala's co-authors include Dalong Qian, Michael F. Clarke, Frederick M. Dirbas, Neethan A. Lobo, George Somlo, Yohei Shimono, Piero Dalerba, Kaiqin Lao, Eric Chiao and Robert W. Cho and has published in prestigious journals such as Science, Cell and Nature Communications.

In The Last Decade

Maider Zabala

22 papers receiving 2.4k citations

Hit Papers

Downregulation of miRNA-200c Links Breast Cancer Stem Cel... 2009 2026 2014 2020 2009 2020 250 500 750

Peers

Maider Zabala
Neethan A. Lobo United States
Debangshu Samanta United States
Keith M. Giles Australia
He Zhou China
Andrea E. Murmann United States
Leni S. Jacob United States
Maider Zabala
Citations per year, relative to Maider Zabala Maider Zabala (= 1×) peers Roger A. Moorehead

Countries citing papers authored by Maider Zabala

Since Specialization
Citations

This map shows the geographic impact of Maider Zabala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maider Zabala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maider Zabala more than expected).

Fields of papers citing papers by Maider Zabala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maider Zabala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maider Zabala. The network helps show where Maider Zabala may publish in the future.

Co-authorship network of co-authors of Maider Zabala

This figure shows the co-authorship network connecting the top 25 collaborators of Maider Zabala. A scholar is included among the top collaborators of Maider Zabala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maider Zabala. Maider Zabala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zabala, Maider, Neethan A. Lobo, Jane Antony, et al.. (2020). LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis. Cell stem cell. 27(2). 284–299.e8. 12 indexed citations
2.
Gulati, Gunsagar S., Shaheen S. Sikandar, Daniel J. Wesche, et al.. (2020). Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 367(6476). 405–411. 712 indexed citations breakdown →
3.
Lobo, Neethan A., Maider Zabala, Dalong Qian, & Michael F. Clarke. (2018). Serially transplantable mammary epithelial cells express the Thy-1 antigen. Breast Cancer Research. 20(1). 121–121. 4 indexed citations
4.
Sikandar, Shaheen S., Angera H. Kuo, Tomer Kalisky, et al.. (2017). Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis. Nature Communications. 8(1). 1669–1669. 45 indexed citations
5.
Isobe, Taichi, Shigeo Hisamori, Daniel J. Hogan, et al.. (2014). miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. eLife. 3. 155 indexed citations
6.
Scheeren, Ferenc A., Angera H. Kuo, Linda J. van Weele, et al.. (2014). A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis. Nature Cell Biology. 16(12). 1238–1248. 97 indexed citations
8.
Parashurama, Natesh, Neethan A. Lobo, Ken Ito, et al.. (2012). Remodeling of Endogenous Mammary Epithelium by Breast Cancer Stem Cells. Stem Cells. 30(10). 2114–2127. 20 indexed citations
9.
Medina‐Echeverz, José, et al.. (2010). Successful Colon Cancer Eradication after Chemoimmunotherapy Is Associated with Profound Phenotypic Change of Intratumoral Myeloid Cells. The Journal of Immunology. 186(2). 807–815. 86 indexed citations
10.
Shimono, Yohei, Maider Zabala, Robert W. Cho, et al.. (2009). Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells. Cell. 138(3). 592–603. 971 indexed citations breakdown →
11.
Zabala, Maider, Pilar Alzuguren, Julien Crettaz, et al.. (2009). Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy. Molecular Cancer. 8(1). 2–2. 34 indexed citations
12.
Shimono, Yohei, Maider Zabala, Robert W. Cho, et al.. (2009). Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells. 138(3). 592–603. 7 indexed citations
13.
Stephen, Sam L., Rubén Hernández-Alcoceba, Pilar Alzuguren, et al.. (2008). Lethality in an anti‐angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1. The Journal of Gene Medicine. 10(10). 1083–1091. 9 indexed citations
14.
Zabala, Maider, Juan José Lasarte, Christine Perret, et al.. (2007). Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer. Journal of Hepatology. 47(6). 807–815. 58 indexed citations
15.
Zabala, Maider, Itsaso Mauleón, Javier De Las Rivas, et al.. (2007). Interleukin-12 inhibits liver-specific drug-inducible systems in vivo. Gene Therapy. 15(4). 277–288. 13 indexed citations
16.
Zabala, Maider, et al.. (2004). Rapid and simple determination of doxycycline in serum by high-performance liquid chromatography. Journal of Chromatography A. 1031(1-2). 295–301. 41 indexed citations
17.
Zabala, Maider, Lin Wang, Rubén Hernández-Alcoceba, et al.. (2004). Optimization of the Tet-on System To Regulate Interleukin 12 Expression in the Liver for the Treatment of Hepatic Tumors. Cancer Research. 64(8). 2799–2804. 49 indexed citations
18.
Hernández-Alcoceba, Rubén, Maider Zabala, Stefan Kochanek, et al.. (2004). 357 A potential therapy for liver metastasis mediated by the inducible expression of interleukin-12 (IL-12) using gutless adenoviral vector. Journal of Hepatology. 40. 108–108. 1 indexed citations
19.
Wang, Lin, Rubén Hernández-Alcoceba, Vijay Shankar, et al.. (2003). Prolonged and inducible transgene expression in the liver using gutless adenovirus: A potential therapy for liver cancer. Gastroenterology. 126(1). 278–289. 68 indexed citations
20.
Barajas, Miguel, Verônica Schmitz, Iñigo Narvaiza, et al.. (2001). Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin-12 (IL-12). Journal of Hepatology. 34. 221–221. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026